Using MRI to find high-risk patients with chronic kidney disease
Functional MRI to Identify High-risk CKD Phenotypes
This study is looking at how a special type of brain scan can help find out which people with chronic kidney disease are more likely to face serious problems like heart issues or kidney failure, so we can create better treatments for them without needing any risky procedures.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Chicago NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project ID | NIH-11050688 on NIH RePORTER |
What this research studies
This research investigates how functional MRI can be used to identify patients with chronic kidney disease (CKD) who are at high risk for serious complications like cardiovascular disease and kidney failure. By using non-invasive imaging techniques, the study aims to assess kidney health without the need for risky biopsies. The goal is to develop new therapies by identifying specific kidney issues, such as fibrosis and hypoxia, that contribute to CKD progression. This approach could lead to better-targeted treatments and improved patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with chronic kidney disease who are at risk for cardiovascular issues and kidney failure.
Not a fit: Patients with acute kidney injury or those without chronic kidney disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier identification and treatment of high-risk CKD patients, potentially reducing the risk of severe complications and improving overall health.
How similar studies have performed: Previous studies have shown promise in using non-invasive imaging techniques for assessing kidney health, indicating that this approach could be effective.
Where this research is happening
Chicago, UNITED STATES
- University of Illinois at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Srivastava, Anand — University of Illinois at Chicago
- Study coordinator: Srivastava, Anand
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.